Výsledky vyhľadávania - "Mesothelioma, Malignant"

Pembrolizumab plus lenvatinib as second-line treatment in patients with pleural mesothelioma (PEMMELA): cohort 2 of a single-arm, phase 2 study.

Autori: Douma LH van der Noort V Lalezari F a ďalší

Zdroj: The Lancet. Oncology [Lancet Oncol] 2025 Dec; Vol. 26 (12), pp. 1676-1684.

Spôsob vydávania: Journal Article; Clinical Trial, Phase II

Informácie o časopise: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Výrazy zo slovníka MeSH: Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/adverse effects , Pleural Neoplasms*/drug therapy , Pleural Neoplasms*/pathology , Pleural Neoplasms*/mortality , Quinolines*/administration & dosage , Quinolines*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Phenylurea Compounds*/administration & dosage , Phenylurea Compounds*/adverse effects , Mesothelioma, Malignant*/drug therapy , Mesothelioma, Malignant*/pathology , Mesothelioma*/drug therapy , Mesothelioma*/pathology , Mesothelioma*/mortality, Humans ; Male ; Female ; Middle Aged ; Aged ; Prospective Studies ; Adult ; Aged, 80 and over

A novel malignant mesothelioma organoids-T cell co-culture platform for personalized immunochemotherapy testing.

Autori: Liu Y Yang Y An S a ďalší

Zdroj: Scientific reports [Sci Rep] 2025 Nov 21; Vol. 15 (1), pp. 41305. Date of Electronic Publication: 2025 Nov 21.

Spôsob vydávania: Journal Article

Informácie o časopise: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Výrazy zo slovníka MeSH: Organoids*/pathology , Organoids*/drug effects , Organoids*/immunology , Precision Medicine*/methods , Mesothelioma, Malignant*/pathology , Mesothelioma, Malignant*/drug therapy , Mesothelioma, Malignant*/immunology , Immunotherapy*/methods , T-Lymphocytes*/immunology , T-Lymphocytes*/drug effects , Lung Neoplasms*/pathology, Humans ; Coculture Techniques/methods

Comprehensive analysis reveals prognostic gene set that could impacts the response to chemotherapy and immunotherapy outcomes in malignant pleural mesothelioma.

Autori: Li J He H Zhang Y a ďalší

Zdroj: Clinical and experimental medicine [Clin Exp Med] 2025 Nov 18; Vol. 26 (1), pp. 22. Date of Electronic Publication: 2025 Nov 18.

Spôsob vydávania: Journal Article

Informácie o časopise: Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE

Výrazy zo slovníka MeSH: Mesothelioma, Malignant*/genetics , Mesothelioma, Malignant*/therapy , Mesothelioma, Malignant*/mortality , Mesothelioma, Malignant*/drug therapy , Immunotherapy*/methods , Pleural Neoplasms*/genetics , Pleural Neoplasms*/therapy , Pleural Neoplasms*/mortality , Biomarkers, Tumor*/genetics , Lung Neoplasms*/genetics , Lung Neoplasms*/therapy , Mesothelioma*/genetics, Humans ; Prognosis ; Female ; Male ; Tumor Microenvironment/genetics ; Gene Expression Regulation, Neoplastic ; Gene Expression Profiling ; Transcriptome ; DNA Methylation ; Cell Line, Tumor ; Antineoplastic Agents/therapeutic use ; Treatment Outcome ; Middle Aged

[Occurrence of Malignant Peritoneal Mesothelioma 19 Years after Concurrent Chemoradiation Therapy for Uterine Cervical Cancer Stage ⅢB-A Case Report and Literature Review].

Autori: Tohya T Ozono K

Zdroj: Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2025 Nov; Vol. 52 (11), pp. 823-824.

Spôsob vydávania: Journal Article; Case Reports; Review; English Abstract

Informácie o časopise: Publisher: Gan To Kagaku Ryohosha Country of Publication: Japan NLM ID: 7810034 Publication Model: Print Cited Medium: Print ISSN: 0385-0684 (Print) Linking ISSN: 03850684 NLM ISO Abbreviation: Gan To Kagaku Ryoho Subsets: MEDLINE

Výrazy zo slovníka MeSH: Chemoradiotherapy*/adverse effects , Lung Neoplasms* , Mesothelioma, Malignant*/diagnosis , Mesothelioma, Malignant*/etiology , Peritoneal Neoplasms*/diagnosis , Peritoneal Neoplasms*/etiology , Uterine Cervical Neoplasms*/therapy , Uterine Cervical Neoplasms*/pathology, Female ; Humans ; Middle Aged ; Fatal Outcome ; Neoplasm Staging ; Time Factors

Distant Metastatic Pattern and Its Prognostic Significance in Malignant Pleural Mesothelioma: A Population-Based Study Based on a Machine Learning Model.

Autori: Yu J Peng C Ye Q a ďalší

Zdroj: The clinical respiratory journal [Clin Respir J] 2025 Nov; Vol. 19 (11), pp. e70133.

Spôsob vydávania: Journal Article

Informácie o časopise: Publisher: Blackwell Publishing Country of Publication: England NLM ID: 101315570 Publication Model: Print Cited Medium: Internet ISSN: 1752-699X (Electronic) Linking ISSN: 17526981 NLM ISO Abbreviation: Clin Respir J Subsets: MEDLINE

Výrazy zo slovníka MeSH: Mesothelioma, Malignant*/mortality , Mesothelioma, Malignant*/pathology , Mesothelioma, Malignant*/secondary , Pleural Neoplasms*/pathology , Pleural Neoplasms*/mortality , Machine Learning* , Lung Neoplasms*/pathology , Lung Neoplasms*/mortality, Humans ; Male ; Female ; Retrospective Studies ; Prognosis ; SEER Program ; Middle Aged ; Aged ; Nomograms ; Neoplasm Staging ; Survival Rate/trends ; Lymphatic Metastasis ; ROC Curve ; Neoplasm Metastasis

Medical Practice Guidelines for Lung Cancers including malignant pleural mesotheliomas and thymic tumors according to evidence-based medicine. 2024. Edited by the Japan Lung Cancer Society. Chapter 3 Guidelines for thymic epithelial tumors - Summary of recommendations.

Autori: Okumura M Fujimoto K Hanaoka N a ďalší

Zdroj: Respiratory investigation [Respir Investig] 2025 Nov; Vol. 63 (6), pp. 1115-1119. Date of Electronic Publication: 2025 Sep 17.

Spôsob vydávania: Journal Article; Practice Guideline

Informácie o časopise: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101581124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2212-5353 (Electronic) Linking ISSN: 22125345 NLM ISO Abbreviation: Respir Investig Subsets: MEDLINE

Výrazy zo slovníka MeSH: Thymus Neoplasms*/therapy , Thymus Neoplasms*/diagnosis , Thymus Neoplasms*/pathology , Evidence-Based Medicine* , Neoplasms, Glandular and Epithelial*/therapy , Neoplasms, Glandular and Epithelial*/diagnosis , Neoplasms, Glandular and Epithelial*/pathology , Lung Neoplasms*/therapy , Lung Neoplasms*/diagnosis , Lung Neoplasms*/pathology , Mesothelioma, Malignant*/therapy , Mesothelioma, Malignant*/diagnosis , Pleural Neoplasms*/therapy , Pleural Neoplasms*/diagnosis , Pleural Neoplasms*/pathology , Practice Guidelines as Topic*, Humans ; Japan ; Societies, Medical ; Neoplasm Staging ; Combined Modality Therapy ; Molecular Targeted Therapy

SCR Disease Name: Thymic epithelial tumor

Discovery of actionable drug targets to enhance T-cell infiltration and immune checkpoint blockade efficacy in pleural mesothelioma.

Autori: Genugten JHLTV Faulkner D Hahne JC a ďalší

Zdroj: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2025 Nov; Vol. 209, pp. 108769. Date of Electronic Publication: 2025 Sep 28.

Spôsob vydávania: Journal Article

Informácie o časopise: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

Výrazy zo slovníka MeSH: Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/pharmacology , Pleural Neoplasms*/drug therapy , Pleural Neoplasms*/immunology , Pleural Neoplasms*/genetics , Pleural Neoplasms*/pathology , Mesothelioma, Malignant*/drug therapy , Mesothelioma, Malignant*/immunology , Lymphocytes, Tumor-Infiltrating*/immunology , Lymphocytes, Tumor-Infiltrating*/drug effects , T-Lymphocytes*/immunology, Humans ; Gene Expression Regulation, Neoplastic ; Molecular Targeted Therapy ; Drug Discovery

Optimizing the pathological diagnosis of diffuse malignant peritoneal mesothelioma.

Autori: Nava FL Kusamura S Shimonovitz-Moore M a ďalší

Zdroj: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2025 Oct; Vol. 51 (10), pp. 110377. Date of Electronic Publication: 2025 Aug 09.

Spôsob vydávania: Journal Article

Informácie o časopise: Publisher: Elsevier Country of Publication: England NLM ID: 8504356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2157 (Electronic) Linking ISSN: 07487983 NLM ISO Abbreviation: Eur J Surg Oncol Subsets: MEDLINE

Výrazy zo slovníka MeSH: Peritoneal Neoplasms*/pathology , Peritoneal Neoplasms*/diagnosis , Peritoneal Neoplasms*/metabolism , Peritoneal Neoplasms*/therapy , Ki-67 Antigen*/metabolism , Ki-67 Antigen*/analysis , Mesothelioma, Malignant*/pathology , Mesothelioma, Malignant*/diagnosis , Mesothelioma, Malignant*/metabolism, Humans ; Retrospective Studies ; Female ; Male ; Middle Aged ; Aged ; Adult ; Biopsy, Large-Core Needle ; Aged, 80 and over ; Cytoreduction Surgical Procedures ; Biopsy ; Hyperthermic Intraperitoneal Chemotherapy

The role of MicroRNAs as early biomarkers of asbestos-related lung cancer: A systematic review and meta-analysis.

Autori: Mukhopadhyay D Cocco P Orrù S a ďalší

Zdroj: Pulmonology [Pulmonology] 2025 Dec 31; Vol. 31 (1), pp. 2416792. Date of Electronic Publication: 2024 Oct 24.

Spôsob vydávania: Journal Article; Meta-Analysis; Systematic Review

Informácie o časopise: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101723786 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2531-0437 (Electronic) Linking ISSN: 25310429 NLM ISO Abbreviation: Pulmonology Subsets: MEDLINE

Výrazy zo slovníka MeSH: Asbestos*/adverse effects , Asbestos*/toxicity , Lung Neoplasms*/diagnosis , Lung Neoplasms*/genetics , Lung Neoplasms*/etiology , Lung Neoplasms*/blood , Mesothelioma, Malignant*/diagnosis , MicroRNAs*/blood, Humans ; Male ; Biomarkers, Tumor/blood ; Occupational Exposure/adverse effects ; Prognosis

Use of Neoadjuvant Immunotherapy in Malignant Peritoneal Mesothelioma as a Bridge to Surgical Intervention: A Case Report.

Autori: Faleh S Odisho T Lebel-Guay F a ďalší

Zdroj: The American journal of case reports [Am J Case Rep] 2025 Nov 09; Vol. 26, pp. e949777. Date of Electronic Publication: 2025 Nov 09.

Spôsob vydávania: Journal Article; Case Reports

Informácie o časopise: Publisher: International Scientific Information, Inc Country of Publication: United States NLM ID: 101489566 Publication Model: Electronic Cited Medium: Internet ISSN: 1941-5923 (Electronic) Linking ISSN: 19415923 NLM ISO Abbreviation: Am J Case Rep Subsets: MEDLINE

Výrazy zo slovníka MeSH: Mesothelioma, Malignant*/therapy , Peritoneal Neoplasms*/therapy , Neoadjuvant Therapy* , Immunotherapy*/methods , Antineoplastic Agents, Immunological*/therapeutic use, Humans ; Female ; Middle Aged ; Cytoreduction Surgical Procedures ; Hyperthermic Intraperitoneal Chemotherapy ; Nivolumab/therapeutic use

Long-term survival of nonoccupational pleural mesothelioma: a case report and review of the literature.

Autori: Tobia L Tolli E Sedile AI a ďalší

Zdroj: Journal of medical case reports [J Med Case Rep] 2025 Oct 21; Vol. 19 (1), pp. 528. Date of Electronic Publication: 2025 Oct 21.

Spôsob vydávania: Journal Article; Case Reports; Review

Informácie o časopise: Publisher: BioMed Central Country of Publication: England NLM ID: 101293382 Publication Model: Electronic Cited Medium: Internet ISSN: 1752-1947 (Electronic) Linking ISSN: 17521947 NLM ISO Abbreviation: J Med Case Rep Subsets: MEDLINE

Výrazy zo slovníka MeSH: Pleural Neoplasms*/therapy , Pleural Neoplasms*/diagnostic imaging , Pleural Neoplasms*/pathology , Mesothelioma, Malignant*/therapy , Mesothelioma*/therapy , Mesothelioma*/diagnostic imaging , Lung Neoplasms*/therapy , Lung Neoplasms*/diagnostic imaging, Humans ; Male ; Middle Aged ; Tomography, X-Ray Computed ; Pneumonectomy ; Thoracentesis

FL496, an FL118-derived small molecule, induces growth inhibition, senescence, and apoptosis of malignant pleural mesothelioma (MPM) cells, and exhibits anti-MPM tumor efficacy strikingly superior to the pemetrexed-cisplatin combination.

Autori: Aljahdali IAM Ling X Wu W a ďalší

Zdroj: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2025 Oct 21; Vol. 44 (1), pp. 293. Date of Electronic Publication: 2025 Oct 21.

Spôsob vydávania: Journal Article

Informácie o časopise: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE

Výrazy zo slovníka MeSH: Mesothelioma, Malignant*/drug therapy , Pleural Neoplasms*/drug therapy , Pleural Neoplasms*/pathology , Antineoplastic Combined Chemotherapy Protocols*/pharmacology , Mesothelioma*/drug therapy , Mesothelioma*/pathology , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology, Humans ; Pemetrexed/pharmacology ; Pemetrexed/administration & dosage ; Animals ; Mice ; Apoptosis/drug effects ; Cisplatin/pharmacology ; Cisplatin/administration & dosage ; Cellular Senescence/drug effects ; Cell Line, Tumor ; Xenograft Model Antitumor Assays ; Cell Proliferation/drug effects ; Mice, SCID ; Disease Models, Animal

Narciclasine as a Novel Treatment for Lung Cancer and Malignant Pleural Mesothelioma: Insights from 3D Tumor Spheroid Models.

Autori: Jiang S Berkcan S Perriraz-Mayer N a ďalší

Zdroj: International journal of molecular sciences [Int J Mol Sci] 2025 Oct 17; Vol. 26 (20). Date of Electronic Publication: 2025 Oct 17.

Spôsob vydávania: Journal Article

Informácie o časopise: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Výrazy zo slovníka MeSH: Spheroids, Cellular*/drug effects , Spheroids, Cellular*/metabolism , Spheroids, Cellular*/pathology , Mesothelioma, Malignant*/drug therapy , Lung Neoplasms*/drug therapy , Lung Neoplasms*/metabolism , Lung Neoplasms*/pathology , Phenanthridines*/pharmacology , Amaryllidaceae Alkaloids*/pharmacology , Pleural Neoplasms*/drug therapy , Pleural Neoplasms*/pathology, Humans ; Apoptosis/drug effects ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Gene Expression Regulation, Neoplastic/drug effects

Global trends, future projections, and epidemiological associations of Mesothelioma: A comprehensive analysis from 1980 to 2050.

Autori: Luan S Wang Y

Zdroj: Cancer epidemiology [Cancer Epidemiol] 2025 Oct; Vol. 98, pp. 102900. Date of Electronic Publication: 2025 Aug 08.

Spôsob vydávania: Journal Article

Informácie o časopise: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101508793 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1877-783X (Electronic) Linking ISSN: 18777821 NLM ISO Abbreviation: Cancer Epidemiol Subsets: MEDLINE

Výrazy zo slovníka MeSH: Mesothelioma, Malignant*/epidemiology , Mesothelioma*/epidemiology , Mesothelioma*/mortality, Humans ; Male ; Female ; Incidence ; Forecasting ; Middle Aged ; Global Health/statistics & numerical data ; Aged ; Occupational Exposure/adverse effects ; Adult ; Asbestos/adverse effects

Risk factors, prognostic factors, and nomograms for distant metastasis in patients with malignant pleural mesothelioma: A population-based retrospective study.

Autori: Lu Q Liu C Xu M a ďalší

Zdroj: The Journal of international medical research [J Int Med Res] 2025 Oct; Vol. 53 (10), pp. 3000605251389356. Date of Electronic Publication: 2025 Oct 30.

Spôsob vydávania: Journal Article

Informácie o časopise: Publisher: Sage Publications Country of Publication: England NLM ID: 0346411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-2300 (Electronic) Linking ISSN: 03000605 NLM ISO Abbreviation: J Int Med Res Subsets: MEDLINE

Výrazy zo slovníka MeSH: Nomograms* , Pleural Neoplasms*/pathology , Pleural Neoplasms*/mortality , Pleural Neoplasms*/epidemiology , Mesothelioma, Malignant* , Mesothelioma*/pathology , Mesothelioma*/mortality , Mesothelioma*/epidemiology , Lung Neoplasms*/pathology , Lung Neoplasms*/mortality, Humans ; Male ; Female ; Risk Factors ; Middle Aged ; Prognosis ; Retrospective Studies ; Aged ; SEER Program ; ROC Curve ; Neoplasm Metastasis ; Adult ; Survival Rate

Efficacy of postoperative immunotherapy on MPM patients after CRS + HIPEC: A single-center retrospective study based on propensity score matching.

Autori: Liang XL Su YD Fu YB a ďalší

Zdroj: International journal of cancer [Int J Cancer] 2026 Jan 01; Vol. 158 (1), pp. 232-242. Date of Electronic Publication: 2025 Sep 02.

Spôsob vydávania: Journal Article

Informácie o časopise: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

Výrazy zo slovníka MeSH: Hyperthermic Intraperitoneal Chemotherapy*/methods , Cytoreduction Surgical Procedures*/methods , Peritoneal Neoplasms*/therapy , Peritoneal Neoplasms*/mortality , Peritoneal Neoplasms*/pathology , Mesothelioma, Malignant*/therapy , Mesothelioma, Malignant*/mortality , Immunotherapy*/methods, Humans ; Female ; Male ; Retrospective Studies ; Middle Aged ; Propensity Score ; Aged ; Combined Modality Therapy ; Adult ; Treatment Outcome ; Prognosis

Genetic variability of HIF1A and response to treatment with cisplatin in combination with pemetrexed or gemcitabine in patients with malignant mesothelioma.

Autori: Setina M Setina E Doljak Z a ďalší

Zdroj: Radiology and oncology [Radiol Oncol] 2025 Sep 05; Vol. 59 (3), pp. 403-411. Date of Electronic Publication: 2025 Sep 05 (Print Publication: 2025).

Spôsob vydávania: Journal Article; Research Support, Non-U.S. Gov't

Informácie o časopise: Publisher: Sciendo Country of Publication: Poland NLM ID: 9317213 Publication Model: eCollection Cited Medium: Internet ISSN: 1581-3207 (Electronic) Linking ISSN: 13182099 NLM ISO Abbreviation: Radiol Oncol Subsets: MEDLINE

Výrazy zo slovníka MeSH: Hypoxia-Inducible Factor 1, alpha Subunit*/genetics , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Mesothelioma, Malignant*/drug therapy , Mesothelioma, Malignant*/genetics , Mesothelioma, Malignant*/mortality, Humans ; Cisplatin/administration & dosage ; Cisplatin/therapeutic use ; Pemetrexed/administration & dosage ; Pemetrexed/therapeutic use ; Polymorphism, Single Nucleotide ; Male ; Gemcitabine ; Female ; Middle Aged ; Retrospective Studies ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/administration & dosage ; Deoxycytidine/therapeutic use ; Aged ; Adult

From asbestos exposure to carcinogenesis: Transcriptomic signatures in malignant pleural mesothelioma.

Autori: Rosati D Maurizi BG Serio VB a ďalší

Zdroj: Experimental and molecular pathology [Exp Mol Pathol] 2025 Sep; Vol. 143, pp. 104973. Date of Electronic Publication: 2025 May 20.

Spôsob vydávania: Journal Article

Informácie o časopise: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0370711 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0945 (Electronic) Linking ISSN: 00144800 NLM ISO Abbreviation: Exp Mol Pathol Subsets: MEDLINE

Výrazy zo slovníka MeSH: Mesothelioma, Malignant*/genetics , Mesothelioma, Malignant*/pathology , Mesothelioma, Malignant*/chemically induced , Asbestos*/adverse effects , Asbestos*/toxicity , Transcriptome*/genetics , Carcinogenesis*/genetics , Carcinogenesis*/chemically induced , Pleural Neoplasms*/genetics , Pleural Neoplasms*/chemically induced , Pleural Neoplasms*/pathology , Lung Neoplasms*/genetics , Lung Neoplasms*/chemically induced , Mesothelioma*/genetics, Humans ; Gene Expression Regulation, Neoplastic/drug effects ; Gene Expression Profiling ; Biomarkers, Tumor/genetics ; Computational Biology/methods ; Gene Ontology

CDKN2A deletion is associated with immune desertification in diffuse pleural mesothelioma.

Autori: Torricelli F Donati B Manicardi V a ďalší

Zdroj: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2025 Aug 28; Vol. 44 (1), pp. 256. Date of Electronic Publication: 2025 Aug 28.

Spôsob vydávania: Journal Article

Informácie o časopise: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE

Výrazy zo slovníka MeSH: Cyclin-Dependent Kinase Inhibitor p16*/genetics , Pleural Neoplasms*/genetics , Pleural Neoplasms*/immunology , Pleural Neoplasms*/pathology , Mesothelioma, Malignant*/genetics , Mesothelioma, Malignant*/immunology , Gene Deletion* , Mesothelioma*/genetics , Mesothelioma*/immunology , Mesothelioma*/pathology, Humans ; Male ; Female ; Retrospective Studies ; Aged ; Middle Aged ; Tumor Microenvironment/immunology

Different Diseases, Different Outcomes: A Comparative Study of Peritoneal and Pleural Subtypes.

Autori: Boutros CS Risa EL Jiang B a ďalší

Zdroj: The Journal of surgical research [J Surg Res] 2025 Aug; Vol. 312, pp. 111-118. Date of Electronic Publication: 2025 Jun 26.

Spôsob vydávania: Journal Article; Comparative Study

Informácie o časopise: Publisher: Academic Press Country of Publication: United States NLM ID: 0376340 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-8673 (Electronic) Linking ISSN: 00224804 NLM ISO Abbreviation: J Surg Res Subsets: MEDLINE

Výrazy zo slovníka MeSH: Peritoneal Neoplasms*/mortality , Peritoneal Neoplasms*/therapy , Peritoneal Neoplasms*/pathology , Peritoneal Neoplasms*/diagnosis , Pleural Neoplasms*/mortality , Pleural Neoplasms*/therapy , Pleural Neoplasms*/pathology , Pleural Neoplasms*/diagnosis , Mesothelioma*/mortality , Mesothelioma*/therapy , Mesothelioma, Malignant*/mortality , Mesothelioma, Malignant*/therapy, Humans ; Male ; Female ; Middle Aged ; Aged ; Retrospective Studies ; Aged, 80 and over ; Adult ; Kaplan-Meier Estimate ; United States/epidemiology ; Treatment Outcome ; Databases, Factual/statistics & numerical data